Pharmaceutical Science 2 (11615.1)
|Available teaching periods||Delivery mode||Location|
|View teaching periods|| On-Campus
|| UC - Canberra, Bruce
|0.125||3||Faculty Of Health|
|Discipline||Study level||HECS Bands|
|Discipline Of Pharmacy||Level 2 - Undergraduate Intermediate Unit|| Band 2 2021 (Commenced After 1 Jan 2021)
Band 3 2021 (Commenced Before 1 Jan 2021)
Learning outcomesOn successful completion of this unit, students will be able to:
1. Summarise the key principles of drug stability, drug discovery, and regulation of new drugs into the market;
2. Justify the purpose and choice of advanced medicine types or formulation systems with reference to clinical outcomes for the patient; and
3. Integrate key patient, drug and/or dosage form related factors that influence bioavailability and apply these to the concept of bioequivalence and other relevant clinical scenarios.
Graduate attributes1. UC graduates are professional - employ up-to-date and relevant knowledge and skills
1. UC graduates are professional - use creativity, critical thinking, analysis and research skills to solve theoretical and real-world problems
2. UC graduates are global citizens - make creative use of technology in their learning and professional lives
2. UC graduates are global citizens - think globally about issues in their profession
2. UC graduates are global citizens - understand issues in their profession from the perspective of other cultures
3. UC graduates are lifelong learners - evaluate and adopt new technology
Prerequisites10288 Pathology, Immunology and Microbiology AND 11614 Pharmaceutical Science 1 AND
11733 Fundamentals of Biochemistry
|Year||Location||Teaching period||Teaching start date||Delivery mode||Unit convener|
|2023||UC - Canberra, Bruce||Semester 2||31 July 2023||On-Campus||Dr Zahid Hussain|
- Michael E Aulton and Kevin M. G. Taylor (eds) (2017) Aulton's Pharmaceutics: The design and manufacture of medicines. (5th edition). Elsevier Churchill Livingstone, Edinburgh. (or 4th edition, 2013)
- Loyd Allen (ed) (2017) Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems. (11th edition). KWW. (or 10th edition 2013)
This Unit contains participatory elements which are vital to the Australian Pharmacy Council professional learning outcomes for this Unit. Except in the case of extenuating circumstances, 100% attendance is expected at all lectures, and 100% participation is required in all tutorials, practicals, and/or other assessable AND non-assessable items. It is expected that students unable to fulfill these participation requirements will inform the Unit Convener as soon as practical, by telephone or email. If attendance requirements cannot be regularly satisfied (e.g. timetable clash) it may be recommended that you schedule this unit for a future semester.
Contact details for the Unit Convenor and the Faculty of Health Placement Administration Office are given in Section 1.
Required IT skills
Students should be conversant with searching for and accessing information via electronic means; the use of CANVAS; and word processing, spreadsheet and presentation software
The following costs are expected for this unit:
- Self-printing of electronically provided materials
- Computer, electronic accessories, and internet access required for online learning
- Purchase of text books and learning material
- Students will need to purchase laboratory coats and safety glasses
Work placement, internships or practicums
There are no work integrated activities for this unit
Privacy and Confidentiality
As part of its partnership arrangements with Health Agencies, the Faculty of Health at the University of Canberra is aware of the issue of confidentiality of information gained from clinical placements and externships. Students are expected to analyse their experiences from these as part of their academic study. In order to support learning while protecting confidentiality of information, the following guidelines have been developed:
1. Pseudonyms should be used for the names of patients and organisations in all academic work.
2. Identifying information, including demographic information, should be modified in academic work, using terminology such as ‘similar to'.
3. Students should mark all academic work with sensitive information as ‘in-confidence' in the footer.
4. Students should develop ‘composite' patients/clients based upon their experiences with several patients or clients in one clinical experience if possible. Students should note that this is a ‘composite' and not intended to identify a single person.
5. Students should use the password-protect function on their word processing programs to further guard sensitive information.
6. Students should avoid naming other students in academic work, such as reflective pieces or portfolios.
7. Students should attend workshops for health science students on how to change information about patients in line with these recommendations.
For further information students may visit https://www.oaic.gov.au/privacy/privacy-for-health-service-providers/
Pharmacy Style Guide for report formatting
Unless otherwise approved (in writing), all written assessment pieces (formative and summative) must conform to the following requirements:
- Headings in bold, maximum font size 16 pt.
- Font size: 11 pt – Times New Roman, Arial or Calibri.
- Margins no less than 1.5cm on all sides.
- Page number at bottom right hand corner of footer.
- Student identification number (number only) at top right hand corner of header.
- References given in NLM/Vancouver style (chronological numeric) ONLY. Information on this referencing styles can be found on the library website at http://www.canberra.edu.au/library/research-gateway/research_help/referencing-guides
- Privacy statements if required (see Section 6g of the Unit Outline).
- Assignment requirements (first page) as per Section 5c above.
- Any word limits specified in assignments (in this Unit Outline or in task descriptions on CANVAS) will INCLUDE all tables, figures and appendices, but EXCLUDE references.
- Submissions which exceed the specified word (or page) length will be truncated at the word (or page) limit and only assessed to this point.
Mandatory Notifications to the Pharmacy Board of Australia
Pursuant to the Health Practitioner Regulation National Law Act 2009, pharmacy practitioners (registered pharmacists) and education providers have an obligation to report ‘notifiable conduct', to the Pharmacy Board of Australia in order to prevent the public being placed at risk of harm.
Education providers are also required, under s.143 of the National Law, to make mandatory notifications in relation to students, if the provider reasonably believes:
1. a student enrolled with the provider has an impairment that, in the course of the student undertaking clinical training, may place the public at substantial risk of harm; or
2. a student for whom the provider has arranged clinical training has an impairment that, in the course of the student undertaking the clinical training, may place the public at substantial risk of harm.
Practitioners are required to make a mandatory notification in relation to a student if the practitioner reasonably believes that a student has an impairment that, in the course of the student undertaking clinical training, may place the public at substantial risk of harm.
All concerns raised within the Discipline of Pharmacy or by clinical preceptors will be reviewed by the Head of Discipline and the Course Convener before any reporting action is taken. These professional obligations are taken seriously by staff and the University. Students should be aware of their obligations under student registration.
For further information, please refer to the Australian Health Practitioner Regulation Agency Pharmacy Guidelines for Mandatory Notifications available at: https://www.ahpra.gov.au/Notifications/Raise-a-concern/Mandatory-notifications.aspx